Highnoon Laboratories approves potential acquisition of undisclosed company

Highnoon Laboratories Limited has approved, in principle, a potential acquisition of an undisclosed target company, the firm said in a notice to the Pakistan Stock Exchange on Monday.

The decision was taken by the board of directors at its meeting held on February 2, 2026, in line with disclosure requirements under the Securities Act, 2015 and PSX Rule Book.

According to the company, the proposed acquisition is expected to support expansion of its business footprint, enhance product portfolio depth and capabilities, and generate operational and commercial synergies, including broader market access and improved distribution efficiencies.

Highnoon said the transaction is currently at an evaluation stage and remains subject to due diligence, negotiations, execution of definitive agreements, receipt of corporate and regulatory approvals, and fulfillment of other customary conditions precedent.

The company said further disclosures will be made as and when required under applicable laws and PSX regulations.